Cervical cancer: trials for referral
615 open trials in the registries we read. Each row links to its registry record.
Registry data only. Frontlight does not judge whether a patient can take part: the trial team decides.
Where the open trials are
Type a city to sort by distance. The distance is worked out in your browser; the city is not sent anywhere.
400 trials shown · Showing the 400 most recently updated of 615 open trials.
Phase 3346 sites
RecruitingPuerto Rico, United States
NCT07061977
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
National Cancer Institute (NCI)
Registry updated 6 Nov 2026
Registry record: ClinicalTrials.govPhase 3200 sites
RecruitingArgentina, Austria, Belgium, Brazil, Canada, Chile
NCT07216703
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
Merck Sharp & Dohme LLC
Registry updated 6 Nov 2026
Registry record: ClinicalTrials.govNo phase1 site
RecruitingCameroon
NCT06669533
Use Misoprostol to Optimize Prevention of Cervical Cancer
University of Alabama at Birmingham
Registry updated 5 Nov 2026
Registry record: ClinicalTrials.govPhase 4130 sites
RecruitingPuerto Rico, United States
NCT06952660
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
Pfizer
Registry updated 5 Nov 2026
Registry record: ClinicalTrials.govPhase 254 sites
RecruitingAustralia, Canada, Switzerland, China, Denmark, Spain
NCT06760819
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Bayer
Registry updated 4 Nov 2026
Registry record: ClinicalTrials.govPhase 139 sites
RecruitingAustralia, China, Spain, France, United Kingdom, Japan
NCT06465069
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Eli Lilly and Company
Pre-treatment window Registry sentence: “Cohort D: Treatment-naive for locally advanced or metastatic urothelial cancer.”
Registry updated 4 Nov 2026 · The registries disagree on the status
Registry record: ClinicalTrials.govPhase 125 sites
RecruitingAustralia, Spain, France, Italy, Japan, South Korea
NCT06400472
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
Eli Lilly and Company
Registry updated 4 Nov 2026
Registry record: ClinicalTrials.govPhase 1/267 sites
RecruitingChina, Japan, South Korea, United States
NCT05579366
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Genmab
Registry updated 4 Nov 2026
Registry record: ClinicalTrials.govPhase 31 site
RecruitingChina
NCT06641635
Moderated Hypofractionated Online Adaptive Radiotherapy in Cervical Cancer
Peking Union Medical College Hospital
Registry updated 3 Nov 2026
Registry record: ClinicalTrials.govPhase 21 site
RecruitingUnited States
NCT05475171
Triage of Advanced Cervical Cancer Through Immunotherapy Induction (TRACTION)
M.D. Anderson Cancer Center
Registry updated 2 Nov 2026
Registry record: ClinicalTrials.govPhase 16 sites
RecruitingUnited States
NCT07524322
Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors
Regor Pharmaceuticals Inc.
Registry updated 2 Nov 2026
Registry record: ClinicalTrials.govPhase 1/23 sites
RecruitingUnited States
NCT07909031
CR-002 in Adult Participants With Locally Advanced or Metastatic Solid Tumors
Crescent Biopharma, Inc.
Registry updated 2 Nov 2026
Registry record: ClinicalTrials.govPhase 21 site
Not yet recruitingCanada
NCT07516210
Adaptive Radiotherapy for Safe Hypofractionation
Centre hospitalier de l'Université de Montréal (CHUM)
Registry updated 29 Oct 2026
Registry record: ClinicalTrials.govNo phase1 site
RecruitingChina
NCT07904182
Hydrogel Spacer During Definitive Radiotherapy for Cervical Cancer
Tianjin Medical University Cancer Institute and Hospital
Pre-treatment window Registry sentence: “Previously untreated disease with no prior pelvic radiotherapy.”
Registry updated 29 Oct 2026
Registry record: ClinicalTrials.govPhase 260 sites
RecruitingAustralia, China, Germany, Spain, France, Italy
NCT06953089
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
DualityBio Inc.
Registry updated 29 Oct 2026
Registry record: ClinicalTrials.govPhase 23 sites
RecruitingUnited States
NCT05686226
E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers
Christian Hinrichs
Registry updated 28 Oct 2026
Registry record: ClinicalTrials.govPhase 112 sites
RecruitingAustralia, United Kingdom, United States
NCT06242470
A Study of MGC026 in Participants With Advanced Solid Tumors
MacroGenics
Registry updated 28 Oct 2026
Registry record: ClinicalTrials.govPhase 12 sites
RecruitingUnited States
NCT05483491
KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung Cancer
Christian Hinrichs
Registry updated 28 Oct 2026
Registry record: ClinicalTrials.govPhase 1/22 sites
RecruitingUnited States
NCT05639972
E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers
Christian Hinrichs
Registry updated 28 Oct 2026
Registry record: ClinicalTrials.govPhase 1/225 sites
RecruitingSpain, Ireland, Puerto Rico, Portugal, United States
NCT07109726
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
Terremoto Biosciences Inc.
Registry updated 28 Oct 2026
Registry record: ClinicalTrials.govNo phase0 sites
Not yet recruiting
NCT07896720
Remote Robotic Surgery for Gynecologic Cancer: A Safety and Effectiveness Study
Women's Hospital School Of Medicine Zhejiang University
Registry updated 27 Oct 2026
Registry record: ClinicalTrials.govPhase 296 sites
RecruitingAustralia, Belgium, Canada, China, Germany, Spain
NCT06172478
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Daiichi Sankyo
Registry updated 26 Oct 2026
Registry record: ClinicalTrials.govPhase 1/2120 sites
RecruitingArgentina, Australia, Belgium, Brazil, Chile, Germany
NCT06330064
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Daiichi Sankyo
Pre-treatment window Registry sentence: “No prior treatment with topoisomerase I inhibitors, such as irinotecan or topotecan.”
Registry updated 26 Oct 2026
Registry record: ClinicalTrials.govPhase 1/2107 sites
RecruitingAustralia, China, Taiwan, United States
NCT05914116
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
DualityBio Inc.
Registry updated 21 Oct 2026
Registry record: ClinicalTrials.govPhase 1/212 sites
RecruitingSouth Korea, United States
NCT04977453
GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid Tumors
GI Innovation, Inc.
Registry updated 19 Oct 2026
Registry record: ClinicalTrials.govPhase 21 site
RecruitingChina
NCT07876154
Iparomlimab/Tuvonralimab Combined With Nab-paclitaxel and Cisplatin as Neoadjuvant Therapy for Locally Advanced Cervical Cancer
Xijing Hospital
Pre-treatment window Registry sentence: “Previously untreated IB3 or IIA2 stage cervical cancer according to the FIGO 2018 staging system;”
Registry updated 15 Oct 2026
Registry record: ClinicalTrials.govPhase 1/26 sites
RecruitingUnited States
NCT06239194
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
ModeX Therapeutics, An OPKO Health Company
Registry updated 15 Oct 2026
Registry record: ClinicalTrials.govPhase 21 site
RecruitingUnited States
NCT07770100
Concurrent Immunotherapy and Systemic Therapy With Stereotactic Body Radiation Therapy (SBRT) for Stage IV Cancers (COINSSS IV)
Mark Bernard
Registry updated 14 Oct 2026
Registry record: ClinicalTrials.govPhase 21 site
RecruitingChina
NCT07202364
A Study of YL202 in Patients With Advanced Solid Tumors
MediLink Therapeutics (Suzhou) Co., Ltd.
Registry updated 14 Oct 2026
Registry record: ClinicalTrials.govPhase 1/24 sites
RecruitingUnited States
NCT07749586
A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
Arvinas Inc.
Registry updated 13 Oct 2026
Registry record: ClinicalTrials.gov
The same sites as a list
- China125 open trials
- United States123 open trials
- Spain21 open trials
- Italy18 open trials
- South Korea18 open trials
- Australia17 open trials
- France16 open trials
- Japan14 open trials
- Germany12 open trials
- Canada12 open trials
- Netherlands12 open trials
- Taiwan11 open trials
- Brazil11 open trials
- United Kingdom10 open trials
- Poland7 open trials
- India7 open trials
- Mexico6 open trials
- Denmark6 open trials
- Kenya6 open trials
- Thailand5 open trials
- Colombia4 open trials
- South Africa4 open trials
- Ireland4 open trials
- Czechia4 open trials
- Sweden4 open trials
- Belgium4 open trials
- Türkiye3 open trials
- Mozambique3 open trials
- Puerto Rico2 open trials
- Chile2 open trials
- Israel2 open trials
- Argentina2 open trials
- Hungary2 open trials
- Switzerland2 open trials
- Portugal2 open trials
- Norway2 open trials
- Uganda2 open trials
- Vietnam2 open trials
- El Salvador2 open trials
- Ethiopia2 open trials
- Slovakia2 open trials
- Austria2 open trials
- Rwanda2 open trials
- Zimbabwe2 open trials
- Botswana2 open trials
- Philippines1 open trial
- Greece1 open trial
- Cameroon1 open trial
- Belarus1 open trial
- Sierra Leone1 open trial
- Egypt1 open trial
- Malaysia1 open trial
- Slovenia1 open trial
- Laos1 open trial
- Congo - Kinshasa1 open trial
- Iran1 open trial
- Zambia1 open trial
- Uzbekistan1 open trial
- Iceland1 open trial
- Serbia1 open trial
- Ghana1 open trial
Who treats this
Institutions with trials or publications in this disease (OpenAlex, registries). Institutions only, no people.
Cancer Hospital of Chinese Academy of Medical Sciences
Beijing, China
12 trials · 32 publications · ROR
What changed in the last 7 days
Registry facts, one per line, newest first.
New in the registry
Use of cfDNA in Monitoring and Guiding Treatment for Cervical Cancer
NCT07919431 · No phase · China
Source: ClinicalTrials.govOpened for recruitment
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
NCT06953089 · Phase 2 · Australia, China, Germany, Spain, France, Italy
Source: ClinicalTrials.govPhase changed: Phase 1 → Early Phase 1
[177Lu]Lu-AKIR001 First-in-human Study
NCT06639191 · Early Phase 1 · Sweden
Source: ClinicalTrials.govClosed for recruitment
First in Human Study of IMGN151 in Recurrent Gynaecological Cancers
NCT05527184 · Phase 1 · Australia, Belgium, Canada, Germany, Spain, France
Source: ClinicalTrials.govPhase changed: Phase 1/2 → Phase 1
First in Human Study of IMGN151 in Recurrent Gynaecological Cancers
NCT05527184 · Phase 1 · Australia, Belgium, Canada, Germany, Spain, France
Source: ClinicalTrials.govStatus changed: Completed → Not yet recruiting
NCT03848039 · Phase 3 · Italy
Source: ClinicalTrials.govStatus changed: Completed → Running, not recruiting
Phase 1-2 Study of ASTX660 in Subjects With Advanced Solid Tumors and Lymphomas
NCT02503423 · Phase 1/2 · Belgium, Canada, Spain, France, United Kingdom, Hungary
Source: ClinicalTrials.govOpened for recruitment
First in Human Study of IMGN151 in Recurrent Gynaecological Cancers
NCT05527184 · Phase 1 · Australia, Belgium, Canada, Germany, Spain, France
Source: ClinicalTrials.govStatus changed: Recruiting → Not yet recruiting
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
NCT06953089 · Phase 2 · Australia, China, Germany, Spain, France, Italy
Source: ClinicalTrials.govPhase changed: No phase → Phase 2
NCT04016389 · Phase 2 · Canada, Italy, Netherlands, United States
Source: ClinicalTrials.govPhase changed: No phase → Phase 3
Long-term Follow-up of Broad Spectrum Human Papillomavirus (HPV) Vaccine Study in Women (V503-021)
NCT02653118 · Phase 3 · Denmark, Norway, Sweden
Source: ClinicalTrials.gov
New reviews, guidelines and randomised trials in PubMed
Systematic review
Frontiers in public health · PubMed
Systematic review
Frontiers in oncology · PubMed
Systematic review
BMC women's health · PubMed
Results card
Trials that finished or stopped in the last 3 years, with the reason the registry gives and linked publications.
No phaseEnded 15 Oct 2026
No phaseEnded 14 Oct 2026
No phaseEnded 1 Oct 2026
Completed17188 participants
NCT07807202
Improving HPV Vaccination Coverage Among Adolescent Girls in Mali and Côte d'Ivoire Through Community Health Worker Follow-up
No phaseEnded 30 Sept 2026
Completed62 participants
NCT06182241
Identifying and Addressing Barriers to Retention in the Cervical Cancer Treatment Cascade Among Women With HIV in South Africa: Part 2
No phaseEnded 1 Sept 2026
No phaseEnded 28 Aug 2026
Phase 1Ended 26 Aug 2026
Stopped early26 participants
NCT03634267
MRI-Guided Brachytherapy in Treating Participants With HPV-Associated Stage IB2-IVA Cervical or Stage II-IVA Vaginal Cancer
Reason given: PI Request
Phase 1/2Ended 21 Aug 2026
Completed55 participants
NCT04708470
A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers
No phaseEnded 21 Aug 2026
Paused1000000 participants
NCT05506800
Guangzhou Women's Health Cohort Study (GWHCS)
Reason given: Due to the rebound of the COVID-19 epidemic in the city, we have to suspend the project temporarily.
No phaseEnded 31 Jul 2026
Completed1000 participants
NCT07768787
Validation of Vaginal Self-Sampling With the Abbott Multi-Collect Swab for HPV Screening in Women Aged 30 to 64 Years
Phase 1/2Ended 31 Jul 2026
Stopped early20 participants
NCT03356795
Intervention of CAR-T Against Cervical Cancer
No reason given in the registry.
Phase 1/2Ended 31 Jul 2026
Stopped early20 participants
NCT03362619
Engineered Immune Effectors Against Cervical Cancer
No reason given in the registry.
Phase 2Ended Jul 2026
Withdrawn before start0 participants
NCT05504642
Chemo-radio-immunotherapy With Nivolumab and Ipilimumab Treatment in Locally Advanced Cervical Cancer Patients
Reason given: Study stopped before submission for funding reasons
Phase 1Ended 31 Jul 2026
Phase 1/2Ended 9 Jul 2026
No phaseEnded 3 Jul 2026
Completed278 participants
NCT06302725
Vaginal Self-sampling for Detecting High-risk Human Papillomavirus Cervical Infection in Patients With Immune-mediated Inflammatory Diseases
No phaseEnded 1 Jul 2026
Completed25 participants
NCT06786091
Late Side-effects After Cervical Cancer Treatment - Prevention and Treatment
No phaseEnded 26 Jun 2026
No phaseEnded 10 Jun 2026
Completed530 participants
NCT07451340
Cross-Cultural Adaptation and Psychometric Validation of the Cervical Cancer Screening Uptake Questionnaire (CCSTQ) in Turkish Women
Phase 1/2Ended 2 Jun 2026
Completed98 participants
NCT05864144
A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors
Show more
Phase 2Ended 2 Jun 2026
Completed12 participants
NCT05021237
Personalized Ultra-fractionated Stereotactic Adaptive Radiotherapy for Metastatic Cervical Cancer
Phase 1Ended 29 May 2026
No phaseEnded 15 May 2026
Completed1264 participants
NCT06874985
Effectiveness and Impact of the Lived Experience Cancer Awareness Campaign on Screening Participation
Phase 1/2Ended 14 May 2026
Completed51 participants
NCT04287868
Combination Immunotherapy in Subjects With Advanced HPV Associated Malignancies
No phaseEnded 12 May 2026
Completed154 participants
NCT07521163
Effect of Health Belief Model-Based Education on Cervical Cancer Knowledge and HPV Vaccine Attitudes in Women
No phaseEnded 30 Apr 2026
No phaseEnded 22 Apr 2026
Completed34 participants
NCT07398313
Effect of Prehabilitation on Recovery Outcomes in Post-Surgical Cervical Cancer Women
No phaseEnded 1 Apr 2026
Phase 1/2Ended 31 Mar 2026
Completed39 participants
NCT04432597
HPV Vaccine PRGN-2009 Alone or in Combination With Anti-PDL1/TGF-Beta Trap (M7824) in Subjects With HPV Associated Cancers
No phaseEnded 27 Mar 2026
Completed755 participants
NCT04122235
The Lifestyle and Empowerment Techniques in Survivorship of Gynecologic Oncology Study
No phaseEnded 23 Mar 2026
Completed72 participants
NCT05461430
Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)
No phaseEnded 20 Mar 2026
Phase 1/2Ended 19 Mar 2026
Completed143 participants
NCT03786081
Efficacy and safety of tisotumab vedotin (HuMax®-TF-ADC) monotherapy and in combination in recurrent or Stage IVB cervical cancer
No phaseEnded 17 Mar 2026
Completed140 participants
NCT06973161
ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors
No phaseEnded 2 Mar 2026
No phaseEnded 28 Feb 2026
Withdrawn before start0 participants
NCT03977311
MR-Guided High-Intensity Focused Ultrasound in Conjunction With Radiation Therapy for the Treatment of Locally Advanced Cervical Cancer
Reason given: PI decided not to go forward with study.
No phaseEnded 27 Feb 2026
Withdrawn before start0 participants
NCT07211204
Comparison Of Cytology And Molecular Screening For Detecting Cervical Reactive Cellular Changes In General Population
Reason given: The study did not start, i.e., no participants were enrolled, because the Mexican Regulatory Authority (COFEPRIS) did not authorize the amendments to the protocol.
No phaseEnded 16 Feb 2026
Completed98 participants
NCT06263283
Impact of an Educational Physiotherapy-Yoga Intervention on Perceived Stress in Women Treated With Brachytherapy for Cervical Cancer
No phaseEnded 5 Feb 2026
Completed40 participants
NCT04008095
Interest of PET/CT at 18F-FDG in the Post-therapeutic Management of Cervical Cancer
No phaseEnded 31 Jan 2026
No phaseEnded 31 Jan 2026
Completed9054 participants
NCT07784283
Integrating HPV Education Into School Health Programs in Cambodia and Kenya
Phase 1Ended Jan 2026
Completed35 participants
NCT02379520
HPV-16/18 E6/E7-Specific T Lymphocytes, Relapsed HPV-Associated Cancers, HESTIA
No phaseEnded 30 Jan 2026
Completed45 participants
NCT06919627
Negative HPV Test Results on Infinity/GeneXpert® With the Presence of a Late Amplification Signal: What Does This Mean ? (PaPCR)
Phase 1/2Ended 28 Jan 2026
Stopped early260 participants
NCT05325866
A Study Evaluating Bemarituzumab in Solid Tumors With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression
Reason given: Sponsor Decision
Phase 3Ended 26 Jan 2026
Phase 1/2Ended 15 Jan 2026
Stopped early5 participants
NCT05357027
HPV16 E6 TCR T Cells for Cervical Carcinoma
Reason given: Study terminated due to strategic portfolio decision to reallocate resources to higher-priority programs
Phase 3Ended 15 Jan 2026
Completed502 participants
NCT04697628
Tisotumab Vedotin vs Chemotherapy in Recurrent or Metastatic Cervical Cancer
- Patient-reported outcomes with tisotumab vedotin versus chemotherapy in patients with recurrent or metastatic cervical cancer: post hoc analyses from the open-label, randomized, phase 3 ENGOT-cx12/GOG-3057/innovaTV 301 trial. · International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2026
- Tisotumab vedotin in Japanese patients with recurrent or metastatic cervical cancer: results from the innovaTV 301/ENGOT-cx12/GOG-3057 trial. · International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2026
No phaseEnded 2 Jan 2026
No phaseEnded 31 Dec 2025
No phaseEnded 31 Dec 2025
No phaseEnded 31 Dec 2025
Completed132 participants
NCT06939699
Social Media-Based Education on Cancer Screening Awareness in Women: A Randomized Controlled Trial
No phaseEnded 31 Dec 2025
No phaseEnded 31 Dec 2025
Completed32949 participants
NCT07821775
Robotic vs Laparoscopic and Open Surgery for Abdominopelvic Cancers
No phaseEnded 30 Dec 2025
Stopped early4 participants
NCT06191900
Clinical Study of GT201 in the Treatment of Advanced Gynecological Tumors (Advanced Cervical Cancer)
Reason given: The study was terminated from a business perspective.
Phase 1Ended 29 Dec 2025
Phase 1Ended 12 Dec 2025
Completed58 participants
NCT05800964
Phase 1 First-In-Human Study to Explore the Safety, Tolerability, and Pharmacokinetics of AMG 305 in Subjects With Advanced Solid Tumors
Phase 1Ended 8 Dec 2025
Completed5 participants
NCT06894771
A Study of MK-4700 Alone or With Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors (MK-4700-001)
No phaseEnded 5 Dec 2025
Stopped early137 participants
NCT01048853
Conservative Surgery in Treating Patients With Low-Risk Stage IA2 or IB1 Cervical Cancer
Reason given: \< 75% participation
Phase 1Ended 3 Dec 2025
Stopped early78 participants
NCT03746431
A Phase 1 Study of [225Ac]-FPI-1434 Injection
Reason given: A strategic decision was made to discontinue the study and prioritize other programs within the portfolio. The study was not discontinued due to safety issues or adverse events related to FPI-1434, FPE-1547, or FPI-1175.
No phaseEnded 30 Nov 2025
Completed797 participants
NCT04557423
Evidence-Based Approach to Empower Asian American Women in Cervical Cancer Screening
Not medical advice. fetched 9 Nov 2026